Follow-The-Filings

Security · featured owners

MIRM

Mirum Pharmaceuticals Inc. COM Equity as of 2026 Q1 among managers we track

  • 2 Owners
  • Max 4.6%
  • $32M
  • 2 add 1 exit

Who owns this now

Largest portfolio weights among featured holders · max 4.6% (Palo Alto Investors) · not free-float ownership

  1. Palo Alto Investors add 4.6%
  2. Polen Capital Management add 0.02%

holders

sorted by % of portfolio · long equity only · exits show last held size · open a manager for their book

history
Palo Alto Investors 2026 Q1 4.6% Add +107.9% 325,175 $30M hist
Polen Capital Management 2026 Q2 stale 0.02% Add +1.8% 20,899 $2M hist
Farallon Capital Management exited 2026 Q2 last 2026 Q1 0% Exit 0.00 pp 3,000 $277K hist

2 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $186.37M $336.89M $521.31M
Gross profit — — —
Gross margin — — —
Net income -$163.42M -$87.94M -$23.36M
Net margin * -87.7% -26.1% -4.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $387.54M $392.79M $549.68M
Total non-current assets * $259.08M $277.97M $293.13M
Total assets $646.62M $670.75M $842.81M
Total current liabilities $87.06M $126.55M $205.8M
Total non-current liabilities * $310.89M $318.56M $322.32M
Total equity $248.67M $225.64M $314.69M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$70.94M $10.32M $55.83M
Cash from investing -$107.2M -$90.12M -$23.95M
Cash from financing $336.6M $17.7M $40.14M
Net change in cash $158.32M -$63.4M $75.24M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders